Cooper, D. S. & Biondi, B. Subclinical thyroid disease. Lancet 379, 1142–1154 (2012).

Article  PubMed  Google Scholar 

Jonklaas, J. & Razvi, S. Reference intervals in the diagnosis of thyroid dysfunction: treating patients not numbers. Lancet Diabetes Endocrinol. 7, 473–483 (2019).

Article  PubMed  Google Scholar 

Walsh, J. P. Thyroid function across the lifespan: do age-related changes matter? Endocrinol. Metab. 37, 208–219 (2022).

Article  CAS  Google Scholar 

Hollowell, J. G. et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 87, 489–499 (2002).

Article  CAS  PubMed  Google Scholar 

Javaid, U., Kennedy, D., Addison, C., Tsatlidis, V. & Razvi, S. Frequency, determinants and costs of thyroid function testing in a laboratory serving a large population. Eur. J. Endocrinol. 186, 553–560 (2022).

Article  CAS  PubMed  Google Scholar 

Yamada, S. et al. The impact of age- and sex-specific reference ranges for serum thyrotropin and free thyroxine on the diagnosis of subclinical thyroid dysfunction: a multicentre study from Japan. Thyroid 33, 428–439 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shan, Z. et al. Iodine status and prevalence of thyroid disorders after introduction of mandatory universal salt iodization for 16 years in China: a cross-sectional study in 10 cities. Thyroid 26, 1125–1130 (2016).

Article  CAS  PubMed  Google Scholar 

Ehrenkranz, J. et al. Circadian and circannual rhythms in thyroid hormones: determining the TSH and free T4 reference intervals based upon time of day, age, and sex. Thyroid 25, 954–961 (2015).

Article  CAS  PubMed  Google Scholar 

Razvi, S. et al. Variation in the reference range limits of thyroid function tests and association with the prevalence of levothyroxine treatment. Eur. J. Endocrinol. 188, K5–K9 (2023).

Article  Google Scholar 

Taylor, P. N. et al. Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study. JAMA Intern. Med. 174, 32–39 (2014).

Article  CAS  PubMed  Google Scholar